NCT03472456

Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

Articaine or Eugenol: a Study on the Choice of Endodontic Medication in the Emergency Management of Irreversible Pulpitis of a Mature Permanent Tooth

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: University Hospital, Strasbourg, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

Detailed description

In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive endodontic medications (Eugenol or Articaine) in order to determine which one is the more efficient to control the pain. These patients would have received the same medication without this study. That's why this is an obsevationnal study.

Conditions

• Pulpitides
• Endodontic Inflammation
• Toothaches
• Operative Dentistry

Interventions

Type	Name	Description
DRUG	Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne	Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne
DRUG	Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol	Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Timeline

• Start date: 2018-03-22
• Primary completion: 2018-03-22
• Completion: 2019-10-24
• First posted: 2018-03-21
• Last updated: 2020-09-17

Locations

1 site across 1 country: France